Paris, France · Founded 2019 · Privately Held (backing)
Developer of a drug discovery platform designed to discover new drugs for specific therapeutic targets. AQEMIA is based in Paris, France and was founded in 2019. Its last reported valuation was $244 million in Dec 2024. It has raised $69.5 million.
Last reported valuation
$243.6M
Oct 2026
Priced at
—
Total raised
$69.5M
Last round
—
Cap table — not yet on record
AQEMIA's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AQEMIA with a free account
·The complete investor list: 12 names
·Watch AQEMIA: the Monday email on marks, rounds and moves
